Martin Shkreli — Albanian Businessman born on December 30, 1983,
Martin Shkreli is an American entrepreneur and financial and pharmaceutical executive. Shkreli is a co-founder of the hedge fund MSMB Capital Management, co-founded and was former CEO of the biotechnology firm Retrophin LLC, and founder and present CEO of Turing Pharmaceuticals AG. In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for Daraprim, and raised its price by 5,500 percent... (wikipedia)